The use of biobanks in research allows studies to be designed to produce
more reliable results in a more efficient way. Biobanks allows large
epidemiological studies to be performed in clearly defined populations in a
relatively short time. Techniques commonly used in biobank based studies
include molecular genetics, proteomics, seroepidemiology, and comparable
genomics.
Biobank based research requires
i.
biobanks with samples from a large number of subjects,
preferably with long follow-up time.
ii.
an extensive system for follow-up to minimise the
proportion of drop-outs and with confidence establish the disease incidences,
for example through the use of a population based health registry.
– To establish a national system for Quality Assurance regarding collection,
handling, storage and documentation of biological samples in Swedish biobanks.
– To compile information on the organisation, content and priority rules
regarding samples in Swedish biobanks and their use.
– To increase knowledge on the usability of Swedish biobank samples.
This is mainly achieved by supporting the gathering of health information on
the biobank samples and by a systematic and technical investigation of the
usability of different kinds of samples.
– To increase knowledge on how biobank based studies should be designed,
especially regarding legal, ethical and statistic questions on the use of biobank
samples.
The previous platform 4, Biobanking and Genetic Epidemiology, in
Wallenberg Consortium North, WCN, has been combined with the previous program
for biobanks in the platform Profiling Polygenic Diseases, Swegene.
Co-ordinator is professor
Our work is divided into the following workpackages:
1. "Good Banking Practice".
Responsible: Göran Hallmans
Annual
report 2003.
Suggestion on SOP: Collection of
blood samples.
2. Biostatistic questions regarding biobanks.
This workpackage have been transferred to the Bioinformatic platform in Wallenberg Consortium North
Responsible: Juni Palmgren
Slutrapport.
3. IT-development.
Investigation of Information Technological possibilities with regard to biobank
samples and information in the Swedish health care system.
Responsible: Kent Lundholm
Annual report 2002.
Investigation: ”Biobanker: Digitalt gränssnitt i sjukvård och
forskning”
4.1 Automated pick-out systems of biobank samples.
Robotized
pick-out system of biobank samples have been installed and is now being
evaluated in the largest research biobank in Sweden.
Responsible: Göran Hallmans
Technical
report BiomekFX 2003.
Annual report 2004.
Appendix III -
annual report 2004.
4.2 Twin Biobank.
Investigates the possibility to establish a biobank connected to the Twin
Registry.
Responsible: Ulf de Faire
Final report 2005.
4.3 DNA extraction.
Service facility for quality assured, large scale DNA extraction of biobank
samples. DNA has now been extracted from all 28 000 participants in the Malmö
Diet and Cancer biobank. The usability of different kinds of biological samples
(buffy coat, formaline fixed tissues, gynecological cellular samples, serum,
dried blood on paper, etc) is systematically evaluated.
Responsible: Göran Berglund och Joyce Carlson
Annual
report 2003.
4.4 DNA Extraction Facility at Karolinska Institutet-Biobank.
Final report 2005.
5.1 Biobank for fresh frozen tissue.
Development of optimised methods for the systematic biobanking of fresh frozen
pathological tissues, including microdissection.
Responsible: Johan Botling
Annual report 2004.
5.2 Database system: a catalogue on tissue samples.
Development and distribution.
Responsible: Bertil Hamberger
5.3 Tissue Arrays.
Automatic systems for production of tissue arrays for effective analysis of
especially valuable or interesting and well-characterised pathological samples.
Responsible: Göran Landberg
Year
report 2003.
Annual
report 2006.
5.4 Brain and proteomics biobanking.
Responsible: Monica Nistér
Protein
Extract Quality.
Protein
Extraction 2003 08 07.
Sample
Handling 2003 08 05.
Final report 2005.
Appendix final report 2005.
6. Multigeneration Registry.
Enhancement of the quality of the Swedish Multigeneration Registry and
demonstration of its usability in biobank based studies.
Responsible: Anders Ekbom
Annual
report 2003.
7. Ethical and legal aspects.
Investigation of ethical and legal requirements for biobank based studies.
Responsible: Mats G. Hansson
Annual
report 2004.
Archived files
All content is © 2003 The
National Biobank Program
Feedback | Privacy policy